Esomeprazole Magnesium
Product Images NDC 45865-892

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 45865-892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsourcer Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (892)

Esomeprazole Magnesium capsules 20 mg packaging label from Medsourcer Pharmaceuticals. The label indicates generic for Nexium, with a count of 30 capsules. It includes dosing instructions to take capsules daily and batch information including lot and expiry date fields. The label also shows peel here instructions on the side.*

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Esomeprazole Fig1)

A line graph titled 'Maintenance of Healing Rates by Month (Study 178)' showing the percent maintained on the y-axis and months on the x-axis. The graph compares healing rate maintenance over six months among four groups: Esomeprazole Magnesium 40 mg, 20 mg, 10 mg, and placebo. Each group is represented by different markers, showing higher maintenance rates for the 40 mg and 20 mg doses compared to 10 mg and placebo.*

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Esomeprazole Fig2)

A line graph titled 'Maintenance of Healing Rates by Month (Study 177)' showing percent maintained on the vertical axis and months on the horizontal axis. The graph compares healing maintenance rates over six months for Esomeprazole Magnesium at 40 mg, 20 mg, and 10 mg doses versus placebo, with distinct lines and markers for each group, displaying higher maintenance rates for the 40 mg dose and lower for placebo.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)

A line graph showing the percent of patients symptom-free of heartburn by study day in Study 225. The graph compares Esomeprazole Magnesium Delayed-Release Capsules at 40 mg and 20 mg doses versus placebo over a 28-day period, with percent symptom-free patients on the y-axis and diary days on the x-axis.*

FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)

Line graph titled 'Percent of Patients Symptom-Free of Heartburn by Day (Study 226)' showing three curves representing Esomeprazole Magnesium Delayed-Release Capsules at 40 mg, 20 mg, and placebo. The x-axis marks Diary Day from 0 to 28 and the y-axis shows Percent of Patients Symptom-Free from 0 to 100. The 40 mg and 20 mg dosage lines trend higher than placebo over time.*

FDA Label Image

Chemical Structure (Esomeprazole Str)

Chemical structure of Esomeprazole Magnesium, showing the molecular arrangement including magnesium ions (Mg2+) and associated chemical groups, with hydration indicated by 2 molecules of water (2H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.